AUG 13, 2026 · PHASE 1 TRIAL
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
ClinicalTrials.gov
This is a Phase 1 interventional trial registration with no posted results; it describes a planned study of ketamine neuropharmacodynamics in depression using imaging biomarkers, still in recruitment.
Reported
Planned enrollment150
Study phasePHASE1
Ketamine dose (primary outcome)0.5 mg/kg over 40 minutes